## Abstract We examined the impact of the subthalamic nuclei (STN) deep brain stimulation (DBS) on the health‐related quality of life (QoL) of patients with advanced Parkinson's disease (PD). Seventeen consecutive patients with refractory motor fluctuations and dyskinesia were included in the study
Negative impact of borderline global cognitive scores on quality of life after subthalamic nucleus stimulation in Parkinson's disease
✍ Scribed by Karsten Witt; Christine Daniels; Paul Krack; Jens Volkmann; Markus O. Pinsker; Manja Kloss; Volker Tronnier; Alfons Schnitzler; Lars Wojtecki; Kai Bötzel; Adrian Danek; Rüdiger Hilker; Volker Sturm; Andreas Kupsch; Elfriede Karner; Günther Deuschl
- Book ID
- 119304162
- Publisher
- Elsevier Science
- Year
- 2011
- Tongue
- English
- Weight
- 370 KB
- Volume
- 310
- Category
- Article
- ISSN
- 0022-510X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Deep brain stimulation (DBS) of the subthalamic nucleus (STN) significantly improves quality of life (QoL) in PD. However, QoL fails to improve in a relevant proportion of patients. We studied clinical baseline and progression parameters associated with improvement in QoL after DBS. Dat
## Abstract We investigated the impact of subthalamic nucleus (STN) deep brain stimulation (DBS) on quality of life (QOL) in patients with advanced Parkinson's disease, as self‐assessed before and after surgery by completing the Parkinson's Disease Questionnaire (PDQ39). In addition to this prospec
## Abstract We evaluated the long‐term effects of subthalamic nucleus (STN) stimulation on health‐related quality of life (HRQL) in patients with advanced Parkinson's disease (PD). STN stimulation improves motor function and decreases medication requirements in patients with advanced PD. The impact